Background Breast cancer associated mortality in Africa remains high due to poor survival
rates, varying widely across countries. Despite medical advancements, barriers like limited …

BACKGROUND: Breast carcinoma ranks the first among malignant tumours in females and
is the chief cause of cancer-related mortality. Androgen in implicated in the induction of …

BACKGROUND: The clinical relevance of androgen receptors (ARs) expressed in breast
cancer cells and the suggested prognostic impact has been an area of active research. The …

Background: Despite the advancement in therapy, breast cancer still remains the most
common malignancy in women globally due in part to its heterogeneity. Triple-negative …

e12584 Background: Triple negative breast cancer (TNBC) is a term that has been applied
to breast cancers which lack expression of three receptors: estrogen receptor (ER) …

Background: Triple-negative breast cancers (TNBC) are the tumors lacking expression of
estrogen receptors, progesterone receptors, and human epidermal growth factor 2. The …

Background: Breast cancer is a big challenging problem for public health. Triple negative
breast cancer (TNBC) is a subtype of breast cancer which is more aggressive; with no …

Background: Breast cancer is the second most common malignancy in Indian women. The
role of estrogen and progesterone receptors (ER and PR) is well established in predicting …

Breast cancer (BC) is considered as one of the most frequent cancers worldwide. GATA3
plays a crucial role in promoting proliferation and differentiation in many tissues including …

Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast
cancer. It accounts for 15–20% of all types of breast cancer. Many research studies have …